Effect of Salmeterol on Dental Plaque and Salivary Properties in 4-10 years old Asthmatic Children treated with Fluticasone propionate

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201302178745N2

Enrollment

Registered

2014-07-20

Start date

2014-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma. chronic asthmatic (obstructive) bronchitis

Interventions

This is a Before and after trial. Forty children aged four to ten years among patients with chronic stable asthma and allergies are referred to Children's Medical Center are selected. The child should

Treatment - Drugs

Eligibility

Sex/Gender

All

Age

4 Years to 10 Years

Inclusion criteria

Inclusion criteria: Children must be at least three months of drug use and fluticasone propionate in controlling symptoms may require treatment with salmeterol.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Measurment of immunoglobolines of saliva. Timepoint: 2 months. Method of measurement: Saliva Testing.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGhasem Meighani

Tehran University of Medical Sciences

mighani@sina.tums.ac.ir+223 78601

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026